5Oltvai Z N, Milliman C L, Korsmeyer S T, et al. Bcl-2 heterolimerizes in vivo with a conserved homologous bax, that accelerater programmed cell death. Cell, 1993, 74:609 -619.
6Krejewski S, Krejewska M, Shabaik A, et al.Immunohistochemical determination of in vivo distribution of Bax, a dominant inhibitor of Bcl-2. Am J Pathol, 1994, 145(6) :1323 - 1336.
7Bargou R C, Daniel P T, Mapara M T, et al. Expression of the bcl-2 gene family in normal and malignant breast tissue: low bax-alpha expression in tumor cells correlates with resistance towards apoptosis. Int J Cancer,1995,60(6) :854 - 859.
8Harnois D M, Que F G, Celli A, et al. Bcl-2 is overexpressed and alters the threshold for apoptosis in a cholangiocarcinoma cell line. Hepatology, 1997,26:885 - 890.
9Sager R. Tumor suppressor genes: the puzzle and the promise,Science, 1989,246(4936 ) : 1406 - 1412.
10Aronson S A. Growth factors and cancer. Science, 1991,254(5035) :1146 - 1153.
